A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...

For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

A new clinical trial is enrolling up to 60 children and young people with solid tumors across the United States and United ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Pancreatic cancer remains one of the deadliest diagnoses in oncology. Only about 13% of patients survive five years, and for ...

Anne Jordan was diagnosed with blood cancer in 2016. After multiple treatments of chemotherapy and radiation, her doctors recommended she consult Dr. Nakhle Saba, director of the CAR-T program at ...

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...

The patient was bedridden and needed daily blood transfusions, and she had tried nine different therapies that didn't bring ...